Search

everythinglearnresearchcommunity

for

Search:↓

Potassium channel openers show promise for treating heart disease and other conditions, but more research is needed to fully understand their effects and safety.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Cyclosporin A helps damaged hair follicles regrow hair quickly.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

Spironolactone is effective and safe for treating acne with minimal side effects.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Nurses are crucial in managing chemotherapy side effects for ovarian cancer patients to improve their quality of life.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

People undergoing chemotherapy need better support and information to cope with hair loss.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

Lower doses of dexamethasone can safely reduce high DHEAS levels in women with androgenic disorders.

The perception of excessive hair growth in women as abnormal is more influenced by cultural norms than by medical reasons.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Obese women had more testosterone and less acne, but similar hair growth compared to non-obese women.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

Minoxidil helps prevent hair loss from chemotherapy in rats.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Different diagnostic criteria greatly affect PCOS diagnosis rates in teenagers.

Normal levels for certain hormones in Chinese women of reproductive age were identified.

Trichotillomania, a disorder where people compulsively pull out their own hair, often starts around age 12, is more common in adult females, and can be treated with behavior therapy and medication.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.